| Application no. and date | 09811296.4 (espacenet) (Federated) (European Patent Register), 20090904 | | Patent/reg. no. and date | DK/EP 2338519, 20160217 | | Publication date | 20110629 | | Priority no. and date | JP 2008228338, 20080905 | | EP pub. no. and date |
EP 2338519 20110629 | | Effective date | | | Applicant/owner | Nitto Denko Corporation, 1-1-2, Shimohozumi
Ibaraki-shi
Osaka 567-8680, JP | | Applicant ref. no. | P58160DK01 | | Inventor | NIITSU, Yoshiro, 2-1-901, Kita 3-jo Nishi 30-chome
Chuo-ku
Sapporo-shi
Hokkaido 064-0823, JP,
MATSUNAGA, Takuya, c/o SAPPORO MEDICAL UNIVERSITY
Minami 1-jo Nishi 16-chome
Chuo-ku
Sapporo-shi
Hokkaido 060-8556, JP | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/07 (2006.01) , A61K 31/7105 (2006.01) , A61K 31/713 (2006.01) , C12N 15/11 (2006.01) | | Title | Middel til behandling af myelofibrose | | Int. application no. | JP2009004369 | | Int. publication no. | WO2010026766 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
